Want to see BBOT full AI Analyst Report?
BridgeBio Oncology Therapeutics (BBOT) Q4 2025 Earnings Report
BBOT Q4 2025 EPS Results
- Actual EPS
- -$0.49
- Consensus EPS
- -$0.63
- Beat/Miss
- Beat by +$0.14
- One Year Ago EPS
- $0.08
BBOT Q4 2025 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 03/05/2026
- Time
- After Close
- Conference Call
- Thursday, March 5, 2026
BBOT Upcoming Earnings
BridgeBio Oncology Therapeutics's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
BBOT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | -0.69- | -1.03 | ― | ― |
| Aug 11, 2026 | 2026 (Q2) | -0.56-0.70 | -50.34 | 98.60% (+49.64) | |
| May 12, 2026 | 2026 (Q1) | -0.51-0.53 | -52.15 | 98.99% (+51.62) | |
| Mar 05, 2026 | 2025 (Q4) | -0.63-0.49 | 0.08 | -690.36% (-0.57) | |
| Nov 12, 2025 | 2025 (Q3) | -0.38-1.03 | 0.1 | -1140.40% (-1.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
